Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Neuro-Oncology Advances|December 8, 2022
Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phaseLauro N Avalos, Tracy L Luks, Tyler Gleason, et al.
Cancers|April 27, 2024
Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary StudyJing Liu, Angela Jakary, Javier E Villanueva-Meyer, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 11, 2024
Altered Iron and Microstructure in Huntington's Disease Subcortical Nuclei: Insight From 7T MRIJingwen Yao, Melanie A Morrison, Angela Jakary, et al.
Neuroimage|December 8, 2022
Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's diseaseJingwen Yao, Melanie A Morrison, Angela Jakary, et al.
Cancer Research|May 31, 2014
Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in gliomaMyriam M Chaumeil, Peder E Z Larson, Sarah M Woods, et al.
AJNR. American Journal of Neuroradiology|March 5, 2025
Clinical Translation of Hyperpolarized <sup>13</sup>C Metabolic Probes for Glioma ImagingAdam W Autry, Yaewon Kim, Duy Dang, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2025
3D spatial sampling to quantify morphologic heterogeneity in isocitrate dehydrogenase-wildtype glioblastomaViva Voong, Sol Beccari, Elaheh Hashemi, et al.
Science Advances|March 12, 2025
Spatial 3D genome organization reveals intratumor heterogeneity in primary glioblastoma samplesQixuan Wang, Juan Wang, Radhika Mathur, et al.
Neuro-Oncology|October 15, 2021
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imagingJulia Cluceru, Yannet Interian, Joanna J Phillips, et al.
Cancer|August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomasMichael Wahl, Susan M Chang, Joanna J Phillips, et al.
Pageof 9